BRIEF published on 08/23/2024 at 09:06, 1 year 3 months ago NuWays AG Reaffirms "Buy" Rating for Einhell Germany AG Post-Q2 Results Sales Growth Q2 Results Einhell Germany AG Power X-Change EBT Margin
PRESS RELEASE published on 08/23/2024 at 09:01, 1 year 3 months ago Original-Research: Einhell Germany AG (von NuWays AG): BUY Einhell Germany AG releases Final Q2 results, confirming guidance. Strong sales performance driven by Power X-Change products. Company to target US market with M&A strategy M&A Strategy Q2 Results Einhell Germany AG Power X-Change Products US Market Entry
BRIEF published on 08/22/2024 at 11:40, 1 year 3 months ago Einhell Maintains Growth Trajectory in First Half of 2024 Revenue 2024 Outlook International Expansion Share Split Power X-Change
PRESS RELEASE published on 08/22/2024 at 11:35, 1 year 3 months ago Half year report: Einhell remains on growth path Einhell Group's half-year report shows impressive revenue growth of EUR 576.2 million, driven by successful battery platform and international expansion strategies Financial Results Revenue Growth International Expansion Einhell Group Battery Platform
BRIEF published on 06/28/2024 at 09:06, 1 year 5 months ago Einhell Germany AG FY24 Guidance Confirmed Amid Solid Q2 Performance NuWays AG FY24 Guidance Einhell Germany AG Power X-Change Q2 Performance
PRESS RELEASE published on 06/28/2024 at 09:01, 1 year 5 months ago Original-Research: Einhell Germany AG (von NuWays AG): Kaufen Einhell Germany AG's Q2 results meet expectations, showing strong sales growth of 11.6% yoy. The company confirms FY24e guidance with a focus on Power X-Change products Sales Growth Q2 Results Einhell Germany AG FY24e Guidance Power X-Change Products
BRIEF published on 06/27/2024 at 15:07, 1 year 5 months ago Einhell Germany AG: Business Development 2024 Financial Performance Sales Forecast Einhell Group Business Development 2024
PRESS RELEASE published on 06/27/2024 at 15:02, 1 year 5 months ago EQS-Adhoc: Einhell Germany AG: Business Development 2024 Einhell Germany AG announces business development for 2024 at Annual General Meeting, expecting EUR 1,030 million sales for the year. Group sales in Jan-May 2024 totaled EUR 478.2 million Sales Business Development Financial Year 2024 Einhell Germany AG
BRIEF published on 05/23/2024 at 09:06, 1 year 6 months ago Einhell Germany AG Reports Positive Q1 Results and Confirms FY24 Guidance International Expansion FY24 Guidance Q1 Results Einhell Germany AG Power X-Change
PRESS RELEASE published on 05/23/2024 at 09:01, 1 year 6 months ago Original-Research: Einhell Germany AG (von NuWays AG): Kaufen Einhell Germany AG's Q1 results meet expectations with solid growth in sales driven by Power X-Change products. Company confirms FY24e guidance, focused on international expansion and accessing the US DIY market International Expansion Q1 Results Einhell Germany AG FY24e Guidance Power X-Change Products
Published on 12/05/2025 at 02:35, 5 hours 10 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 45 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 40 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 45 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 45 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 15 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 54 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 20 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 30 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 45 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 1 minute ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
